Evidence map›Paper›PMID 28854943›Full record

ArticleHarm reduction journal2017

A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in Haiphong, Vietnam.

Pham Minh Khue, Nguyen Thi Tham, Dinh Thi Thanh Mai, Pham Van Thuc, Vu Minh Thuc, Pham Van Han, Christina Lindan

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Pham Minh KhueHaiphong University of Medicine and Pharmacy, 72A, Nguyen Binh Khiem, Ngo Quyen, Haiphong, Vietnam.
Nguyen Thi ThamHaiphong University of Medicine and Pharmacy, 72A, Nguyen Binh Khiem, Ngo Quyen, Haiphong, Vietnam.
Dinh Thi Thanh MaiHaiphong University of Medicine and Pharmacy, 72A, Nguyen Binh Khiem, Ngo Quyen, Haiphong, Vietnam.
Pham Van ThucHaiphong University of Medicine and Pharmacy, 72A, Nguyen Binh Khiem, Ngo Quyen, Haiphong, Vietnam.
Vu Minh ThucHaiphong University of Medicine and Pharmacy, 72A, Nguyen Binh Khiem, Ngo Quyen, Haiphong, Vietnam. vuminhthuc2001@gmail.com.
Pham Van HanHaiphong University of Medicine and Pharmacy, 72A, Nguyen Binh Khiem, Ngo Quyen, Haiphong, Vietnam.
Christina LindanGlobal Health Sciences, University of California, UCSF, 550 16th Street, Third Floor, San Francisco, CA, 94158, USA.
Hai phong University Of Medicine and Pharmacy · VN

Funding

Int'l Traineeships in AIDS Prevention Studies (ITAPS)R25MH064712 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LINDAN, CHRISTINA P · 2002 to 2018
$3.4M
NCHHSTP CDC HHS U2G PS001468NIMH NIH HHS R25 MH064712
6 · The paper itself

Abstract

backgroundVietnam began providing methadone maintenance therapy (MMT) in 2008; as of June 2016, 44,479 persons who inject drugs (PWID) were in treatment in 57 provinces. However, 10-23% of patients were estimated to have dropped out of treatment during the first 2 years. We evaluated dropout and factors associated with quitting treatment.

methodsWe followed clients ≥ 18 years old enrolled in five MMT clinics in Haiphong for 3 years. Persons who missed a consecutive month of methadone treatment were considered to have dropped out and were not allowed to return; those who missed greater than five consecutive doses were considered to be non-compliant but were allowed to restart treatment at their initial dose. Clients who dropped out or who were non-compliant during their third year of MMT (cases) were traced and matched with two clients who remained in treatment (controls) by gender, age, and length of time in the program. Cases and controls were interviewed. Additional data on levels of yearly retention were abstracted from clinic records.

resultsAmong the 1055 patients initially enrolled in MMT, dropout and non-compliance combined was 13.6% during the first year, 16.5% during the second year, and 22.3% during the third year. By 36 months, 33.3% of clients had dropped out, of whom 10.6% had died and 24% had been arrested. We traced and interviewed 81 clients who dropped out or who were non-compliant during year 3 as well as 161 controls. The primary reasons for dropping out included claiming no dependence on heroin (22.2%), conflict with work (21.0%), health problems (16.0%), and inability to afford the methadone co-payment of approximately 0.5 USD/day (14.8%). Independent factors associated with non-compliance included continuing to use heroin (aOR = 12.4, 95% CI 4.2-36.8) and missing greater than three doses during the previous 3 months (aOR = 18.5, 95% CI 7.4-47.1); receiving a daily dose of > 120 mg of methadone was associated with a lower odds ratio of dropping out (aOR = 0.3, 95% CI 0.1-0.9).

conclusionBy 3 years, one third of all patients in treatment had permanently dropped out. Ensuring that methadone dosing is adequate and reducing or eliminating the co-payment fee for those who cannot afford it could improve retention.

Indexed as

AdolescentAdultCase-Control StudiesCohort StudiesDrug UsersFemaleHeroin DependenceHumansLongitudinal StudiesMaleMethadoneMiddle AgedNarcoticsOpiate Substitution TreatmentPatient CompliancePatient DropoutsMethadoneNarcoticsDropoutDrug useHIVMethadone maintenance treatmentOpioid substitutionVietnam

Identifiers

PMID28854943
PMCPMC5577787
OpenAlexW2750905202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.